Analysts Offer Insights on Healthcare Companies: Healthequity (HQY), Cellectis SA (CLLS) and Idexx Laboratories (IDXX)
TipRanksApr 30 05:35 ET
Barclays Remains a Buy on Cellectis SA (CLLS)
TipRanksApr 30 05:33 ET
Express News | Cellectis Q4 2023 GAAP EPS $(0.64) Misses $(0.26) Estimate, Sales $1.990M Miss $16.263M Estimate
BenzingaApr 29 16:49 ET
Cellectis Believes Cash Runway Is Extended Into 3Q of 2025 and Will Be Able to Operate for at Least 12 Mos Following Consolidated Fincl Statements
Cellectis Believes Cash Runway Is Extended Into 3Q of 2025 and Will Be Able to Operate for at Least 12 Mos Following Consolidated Fincl Statements
Dow JonesApr 29 16:48 ET
Cellectis 4Q Loss/Shr 64c >CLLS
Cellectis 4Q Loss/Shr 64c >CLLS
Dow JonesApr 29 16:46 ET
Press Release: Cellectis Reports Financial Results for the Fourth Quarter and Full Year 2023
Cellectis Reports Financial Results for the Fourth Quarter and Full Year 2023 -- Preliminary results of NATHALI-01 and updated results of BALLI-01 Phase I clinical studies presented at the American
Dow JonesApr 29 16:46 ET
European Equities Traded in the US as American Depositary Receipts Trend Higher in Friday Trading, End Week Up 3.4%
European equities traded in the US as American depositary receipts were trending higher Friday morning, rising 0.5% to 1,380.32 on the S&P Europe Select ADR Index. With the gain, the index is set to c
MT NewswiresApr 26 11:09 ET
European Equities Traded in the US as American Depositary Receipts Trend Modestly Higher in Thursday Trading
European equities traded in the US as American depositary receipts were trending modestly higher Thursday morning, rising 0.24% to 1,364.10 on the S&P Europe Select ADR Index. From continental Europe,
MT NewswiresApr 25 11:06 ET
European Equities Traded in the US as American Depositary Receipts Trend Lower in Wednesday Trading
European equities traded in the US as American depositary receipts were trending lower Wednesday morning, declining 0.9% to 1,356.02 on the S&P Europe Select ADR Index. From continental Europe, the ga
MT NewswiresApr 24 11:11 ET
Cellectis Unveils Groundbreaking Gene-Editing Advances
TipRanksApr 22 17:27 ET
Express News | Cellectis To Present Data On TALEN Editing Process At ASGCT Mat 7-11
Moomoo 24/7Apr 22 16:38 ET
Cellectis Presents Novel TALEN Editing Processes Enabling Highly Efficient Gene Correction and Gene Insertion in HSPCs
This novel editing approach might unlock new strategies for the treatment of metabolic and neurological diseasesNon-viral circular ssDNA delivery associated to TALEN gene editing allows high levels of gene
GlobeNewswireApr 22 16:30 ET
European Equities Traded in the US as American Depositary Receipts Rebound in Monday Trading
After closing out last week more than 2% lower, European equities traded in the US as American depositary receipts rebounded Monday morning, rising 1.09% to 1,340.58 on the S&P Europe Select ADR Index
MT NewswiresApr 22 11:03 ET
European Equities Traded in the US as American Depositary Receipts Trend Higher in Friday Trading But End Week Down
European equities traded in the US as American depositary receipts were trending higher Friday morning, rising 0.46% to 1,330.20 on the S&P Europe Select ADR Index. Despite the gain, the index remains
MT NewswiresApr 19 11:10 ET
European Equities Traded in the US as American Depositary Receipts Lower in Tuesday Trading
European equities traded in the US as American depositary receipts were lower Tuesday morning, declining 0.67% to 1,332.69 on the S&P Europe Select ADR Index. From continental Europe, the gainers were
MT NewswiresApr 16 11:15 ET
European Equities Traded in the US as American Depositary Receipts Start Week Higher in Monday Trading
European equities traded in the US as American depositary receipts kicked off the week trending moderately higher Monday morning, rising 0.53% to 1,352.74 on the S&P Europe Select ADR Index. From cont
MT NewswiresApr 15 11:08 ET
European Equities Traded in the US as American Depositary Receipts Decline in Thursday Trading
European equities traded in the US as American depositary receipts were weaker Thursday morning, falling 0.91% to 1,353.49 on the S&P Europe Select ADR Index.
MT NewswiresApr 11 11:11 ET
Cellectis Unveils Gene Therapy Breakthrough
TipRanksApr 11 04:38 ET
Express News | Cellectis Publishes Novel Intronic Gene Editing Approach For Inborn Metabolic Diseases By Edited HSPCs
Moomoo 24/7Apr 10 16:31 ET
Cellectis Publishes a Novel Intronic Gene Editing Approach For the Treatment of Inborn Metabolic Diseases by Edited HSPCs
NEW YORK, April 10, 2024 (GLOBE NEWSWIRE) -- Cellectis (the "Company") (NASDAQ:CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies,
GlobeNewswireApr 10 16:30 ET
No Data
No Data